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We are grateful to Drs Gelsomino
and Romano for their interest in our
article.1 They raise several important
issues related to the adequacy of in-
vestigating the cardiovascular system
bymeans of the pressure recording an-
alytical method (PRAM) and to the
methods used to attenuate the risk
of underdamping/resonance artifacts
in vivo, potentially responsible for an
incorrect measurement of hemody-
namic parameters.1,2
Dynamic response artifacts are often
observed in patients receiving periph-
eral monitoring based on pulse contour
analysis.3 In particular, underdamping
effects are frequently observed when-
ever the stiffness of the cardiovascular
system, including the apparatus for
pulse pressure ‘‘transduction,’’ is aug-
mented.3,4 Therefore, conditions such
as systemic arterial hypertension, se-
vere calcified ascending aorta, diffuse
atherosclerosis of the aortic arch,
systemic vasoconstriction, hypovole-
mic conditions, and a stiff trans-
duction system (related to the use of
numerous stopcocks, stiff tubes, and
arterial transduction catheters) all
contribute to increase the risk for
dynamic response artifacts.3,4
Although transducers ad hoc manu-
factured to avoid underdamping arti-
facts exist on the market,3 they were
not available at our institution at the
time of the study and therefore were
not used. Accordingly, our detection
system might have been unable to rec-
ognize and consequently ‘‘clean’’ pos-
sible dynamic artifacts.
However, as for any detection sys-
tem based on pulse contour analysis,
the recorded variables were validated890 The Journal of Thoracic and Cby an expert operator. For a correct in-
terpretation of any data, the PRAM
method undeniably requires a proper
recognition of the dicrotic notch
(which can be easily misrecognized
by the machine and in cases of
underdamping/resonance artifacts).
Therefore, back to Gelsomino and Ro-
mano’s question, no data were col-
lected in our study unless validated
by a fully trained operator. Therefore
whenever artifacts existed, the detect-
ing system was ‘‘restarted’’ to achieve
a correct recognition of the pulsewave,
thus collecting data only when the sys-
tem properly interpreted the pulse.
An additional troubleshooting ma-
neuver was to move to a different arte-
rial site to derive a ‘‘correct’’ pulse
wave (mainly the common femoral ar-
terial access, where artifacts were less
commonly encountered in our experi-
ence). Furthermore, the transduction
systemwas a priori optimized by using
only 1 stopcock and flexible tubing/ar-
terial catheters, and only 20F catheters
for radial transduction or 18F cathe-
ters for femoral transduction.
These problems were rarely encoun-
tered during the study because of the
setting and the peculiar hemodynamic
pattern of the enrolled population: Pa-
tients weaned from an intra-aortic bal-
loon pump (IABP) are usually
vasodilated (because of the IABPeffect
or the concomitant use of vasodilating
drugs); moreover, patients with severe
atherosclerotic aortic arch or thoracic
descending aorta did not undergo trans-
femoral IABP because of institutional
policies (and thus were not enrolled in
this study). Given the peculiar design
of the trial, based on the hemodynamic
monitoring and surveillance of a poten-
tial perioperative low cardiac output
state after weaning, all patients were
maintained at proper preload (central
venous pressure maintained at 8-12
mm Hg) and afterload states: thus,
conditions such as vasoconstriction
and hypovolemia, potentially favoring
underdamping/resonance artifacts,were
avoided. On the basis of this approach,
it can be easily recognized that theardiovascular Surgery c March 2013most common causes of underdamping
were prevented but overall rare in this
specific patient population.
In addition, wewant to underscore 3
major validation aspects of our study:
1. Before using PRAM, we per-
formed a ‘‘cross-check’’ validation
of data via a pilot study. We ana-
lyzed the reliability of hemody-
namic indices derived from
PRAM compared with those de-
rived by the traditional Swan–
Ganz thermodilution method. As
in other reports,5 this preliminary
study demonstrated a perfect
agreement between PRAM and
Swan–Ganz data, unless paroxys-
mal high-rate atrial fibrillation oc-
curred. However, a new onset of
high-rate atrial fibrillation did not
occur in our patients during the
weaning trial. Of note, a new onset
of high-rate atrial fibrillation at our
institution is considered a contrain-
dication to the progression of an
IABP-weaning trial.
2. Our trialwas designed to investigate
at 360 degrees the impact of the 2
weaning strategies on the entire car-
diovascular system. Accordingly,
hemodynamic and biochemical
indices were collected, such as tro-
ponin I and lactate, the former
showing the myocardial perfusion
and the latter showing the adequacy
of peripheral ‘‘oxygenation.’’
Again, peripheral lactate confirmed
the superiority of the ‘‘volume-
deflation’’ method versus the ‘‘rate-
reduction’’ strategy in terms of
peripheral perfusion.
3. Romagnoli and colleagues3 have
demonstrated that whenever under-
damping/resonance effects exist,
significant differences are recorded
betweenhemodynamic data derived
from ‘‘conventional’’ PRAM and
those derived from underdamping/
resonance-corrected PRAM by
means of specific transducers. As
we mentioned, these transducers
were not available at the time we
started the study. Furthermore, an
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that study in terms of systemic arte-
rial pressure and dP/dtMAX (vari-
ables not collected in our study
and not considered as end points
of the trial), but a less important
‘‘delta’’ (although statistically sig-
nificant) was recorded for cardiac
index and cardiac cycle efficiency
(magnitude 0.24 L/min for
cardiac index and 0.018 units for
cardiac cycle efficiency, respec-
tively).3 However, these ‘‘deltas’’
were registered in an animal model
during systemic hypertensive con-
ditions (mean values of systolic
blood pressure ranging from 160
to 174 mm Hg),3 a hemodynamic
pattern distant from that of a vasodi-
lated patient in stable hemodynamic
condition, as in our hemodynami-
cally oriented IABP-weaning trial.
We strongly believe that the magni-
tude of these ‘‘deltas’’ in patients
with an overall good hemodynamic
performance, especially when con-
firmed by other hemodynamic, bio-
chemical, and clinical data, should
beconsiderednegligible fromaclin-
ical perspective.
Finally, we assume that the mea-
surement of any biological process
is truly a difficult task, and that the
trend over time of a hemodynamic in-
dex, rather than its absolute value at
a single time, is important in clinical
practice, as in the case when evaluat-
ing 2 different IABP-weaning strate-
gies. Accordingly, considering that
most of the mentioned mechanisms
responsible for a ‘‘high’’ cardiovas-
cular stiffness are unavoidable and
constant in a given patient, provided
that a good transduction setting is
used and that preload and afterload
have been adequately corrected, we
still consider that the traditional
PRAM method (in the absence of ad
hoc manufactured transducers) can
be reliable in clinical practice, as
long as a proficient human validation
phase of the PRAM-derived indices
is provided.The JournalWe are pleased that our study con-
firmed, for the first time in humans,
the important findings found by Gel-
somino and colleagues6 in a swine
model of acute ischemia, in which he-
modynamic indices and cardiac con-
tractile efficiency parameters were
similarly derived by conventional
PRAM methodology, showing the
same inadequacy of 1:2 and 1:3
IABP assisting rates on hemodynamic
recovery.
We hope that these endeavors,
taken together, can open the way to
a new paradigm when weaning pa-
tients from IABP support.
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ENDOCARDECTOMY DURING
SURGICALVENTRICULAR
RECONSTRUCTION?
To the Editor:
In a recent article in the Journal,
Babokin and colleagues1 presented
results after surgical ventricular recon-
struction (SVR) together with endo-
cardectomy along radiofrequency
ablation–induced markings. The ob-
jective was to evaluate the efficacy of
a new approach for endocardectomy
during SVR in patients with post-
infarction left anteroseptal ventricular
aneurysms. The extent of the endocar-
dectomy was guided by preoperative
electroanatomic mapping and mark-
ings produced by radiofrequency abla-
tions. The design was a retrospective
single-center study, and 168 patients
were included and categorized in 2
groups: 74 patients who underwent
SVR including endocardectomy and
94 patients who underwent SVR.
Whether or not endocardectomyshould
have been added to SVR was decided
by the surgeon. All patients also under-
went coronary artery bypass grafting.
In the SVR þ endocardectomy group
and SVR only group, early mortality
was 1% and 6%, respectively, and
1-year mortality was 5% and 13%,
respectively. Cardiac function and vol-
umes were similar between the groups
both before and after surgery. In a sub-
group of patients who underwent both
pre- and postoperative electrophysio-
logic studies, Babokin and colleagues1
found a lower incidence of spontaneous
and induced ventricular tachycardia
(VT)after surgery inpatientswhounder-
wentSVRþ endocardectomycompared
with SVR only. There were also fewer
implantable cardioverter-defibrillators
(ICDs) in the SVR þ endocardectomy
group.
Patients are at risk for malignant
arrhythmias after SVR; however,
whether the risk is high2 or low3 is un-
clear. One strategy would be to use
ICDs routinely after SVR. However,
there are downsides to ICD use, forry c Volume 145, Number 3 891
